Moores UCSD Cancer Center investigators have begun a clinical trial of a new treatment for chronic lymphocytic leukemia.
The study, a Phase I safety trial, is enrolling selected patients whose leukemia has resisted initial treatment or who have a particular chromosomal abnormality.
The study is headed by Dr. Januario E. Castro and employs a new leukemia vaccine that was developed from the work of Dr. Thomas J. Kipps.
Januario E. Castro, M.D., is Assistant Professor of Medicine in the Division of Bone Marrow Transplantation.
Thomas J. Kipps, M.D., Ph.D., is Professor of Medicine in the Division of Hematology-Oncology and Deputy Director for Research at the Moores UCSD Cancer Center.
Read the full story
from UC San Diego
Health Sciences Communications